US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Pileseptin is now available for sale at Apotek Hjärtat

Double Bond Pharmaceuticals subsidiary Drugsson AB, distributor of Pileseptin in the Nordic market, reports that Pileseptin in both gel and spray form is now available at Apotek Hjärtat. Earlier this year the product became available at APOHEM, Apotea, Apotek365 and Meds.se in Sweden as well as on Webpharma in Norway. "We are happy to now have our first marketed non-prescription product in one of the largest pharmacy chains in Sweden and we continue to work towards establishing deals with other sales channels in the future," comments Igor Lokot, CEO at Double Bond Pharmaceutical and

Double Bond Pharma signed a distribution agreement with Euroresearch Srl

Double Bond Pharmaceutical (DBP) has signed an agreement with Euroresearch Srl for the distribution of their selected products on the Scandinavian market. The sales of these products will be handled by DBP’s subsidiary Drugsson AB. The products, Biospray and Biopad, are medical devices and are used for the treatment of minor burns, skin irritation, wounds, bed sores, diaper- and incontinence rash, skin damage and abrasions, hemostat. Drugsson will market the products to both consumers (self-care) and healthcare, which means that the products have a broad potential market. As always,

DBP partners with Webpharma SPT in Norway

Double Bond Pharmaceuticals subsidiary Drugsson has signed a distribution agreement with Webpharma SPT in Norway. According to the agreement, Webpharma will be Drugsson's wholesaler and distribution partner in the Norwegian market. "With this agreement, we now have a partner who has a great experience in the Norwegian market," comments Igor Lokot, CEO of Double Bond Pharma and Drugsson AB. – This collaboration will substantially propel Drugssons expansion to Norway”. Webpharma SPT are also active on the health care professional market and supplies pharmaceuticals to clinics and

DBP starts delivering Pileseptin to Norway

Double Bond Pharmaceuticals subsidiary Drugsson has now started delivering Pileseptin to Fyrstikktorget pharmacy in Norway. "As a step towards growth and development of Drugsson we have now started to expand our sales to other Nordic countries", comments Igor Lokot, CEO of Double Bond Pharma and Drugsson AB. More about Fyrstikktorget apotek: www.apotekhjem.no More about Pileseptin: It's a new treatment for hemorrhoids that works effectively by reducing swelling and keeping the area clean from bacteria and dirt. Pileseptin Spray is used against external hemorrhoids and Pileseptin

Pileseptin gel is now available for sale at Apotek365

Double Bond Pharmaceuticals subsidiary Drugsson AB, distributor of Pileseptin in the Nordic market, reports that Pileseptin gel is now available at Apotek365. The product will also be available on Meds.se shortly. Pileseptin in spray form is already available on the market since January. "We are happy to have our first non-prescription product on the market in both its forms and work to establish a deal with several other sales channels in the future," comments Igor Lokot, CEO at Double Bond Pharmaceutical and Drugsson AB, - We continue also to look for new, sought-after products that

Clinical trial of Inofer: last patient in

The last patient of twenty has now been included in the clinical study of the iron tablets Inofer, which Drugsson AB (subsidiary of Double Bond Pharmaceutical) has the rights to distribute in Sweden, Norway, Denmark and Finland. A clinical trial of Inofer was approved, as previously reported, by the Swedish Medical Products Agency and the National Ethical Committee June 20, 2018, and started on October 4 when the first patient received treatment with Inofer tablets. The study is being conducted at Skellefteå Hospital and is led by chief physician Kurt Boman, senior professor at Umeå

Pileseptin spray is now available for sale at MEDS.se

Double Bond Pharmaceuticals subsidiary Drugsson AB, which is a distributor of Pileseptin in the Nordic market, reports today that Pileseptin spray is now available at Meds.se. The product, as reported earlier, is since last week available on Apotek365. "We are happy to have our first marketed non-prescription product available on the additional sales channel, - comments Igor Lokot, CEO at Double Bond Pharmaceutical and Drugsson AB, - We continue to look for new, sought-after products that may be of interest to Drugssons pipe line". More about Pileseptin: It's a new treatment for

Pileseptin Gel now available at Tamro central warehouse

Double Bond Pharmaceuticals subsidiary Drugsson AB, distributor of Pileseptin on the Nordic market, has received its first delivery of Pilseptin gel to Sweden. The products are stored at Tamro who is Drugsson’s partner for warehousing and logistics. Pileseptin Gel is manufactured in France and will be available for the Swedish market at Meds.se and Apotek365 soon. Pileseptin Spray is available for purchase in Sweden through Apotek365 since 21stof January 2019 . At the same time, Drugsson AB is working to sell these products to more web-

Clinical trial of Inofer: half of the patients already recruited

The tenth patient of twenty has now been recruited for the clinical study of the iron tablets Inofer, which Drugsson AB (subsidiary of Double Bond Pharmaceutical) has the rights to in Sweden, Norway, Denmark and Finland. This means that the study is proceeding according to plan. The clinical trial of Inofer was approved as previously reported, by the Swedish Medical Products Agency and the Ethical vetting board on 20 June, commencing on October 4 when the first patient received treatment with Inofer tablets. The study is conducted at Skellefteå Hospital and is led by chief physician Kurt

Double Bond Pharma signs agreement for distribution of Helixor products

Double Bond Pharmaceutical (DBP) and Helixor Heilmittel GmbH have today signed an agreement for distribution of Helixor products in Sweden. The distribution will be held through Drugsson AB. Helixor products are used as integrative cancer therapy, which means that they are given to the patient to decrease severe side effects from their current medication and substantially increase quality of life. Helixor products are available for integrative treatment of different types of cancers, both common and rare cancers, including breast cancer, colorectal cancer, lung cancer and brain cancer.

Double Bond Pharma signs logistics agreement with Tamro

Today, Double Bond Pharmaceutical has signed an agreement with the wholesaler Tamro for distribution and storage of its product Pileseptin in Sweden, Norway and Denmark. Tamro is Sweden’s only independent pharmaceutical logistics service provider and is known to have both the world-class knowledge and experience in this type of services. Pileseptin, a product that Double Bond signed a distribution agreement for in December 2017, is an innovative formulation that strengthens the healing effect of hemorrhoids, and is part of Double Bond’s venture into drug distribution through its subsidiary

Double Bond Pharma signs agreement for distribution of Pharysol

Double Bond Pharmaceutical (DBP) and Vitro-Bio have today signed an agreement for distribution of Pharysol in Sweden, Norway and Denmark. The distribution will be held through Drugsson AB. "In line with our goal to build a self-sustaining pharmaceutical company with a balanced portfolio consisting of both innovative development products and ready-to-sell unique products we are very pleased to be able to expand our collaboration with Vitro-Bio in terms of distribution of broader line of their products. Pharysol is a treatment against common cold and expected to bring the largest revenue

Double Bond Pharma signs distribution agreement with Belmedpreparaty

Double Bond Pharmaceutical (DBP) has signed an agreement with RUE Belmedpreparaty for distribution of selected dietary supplements on the Scandinavian market. Sales of these products will be managed by the newly established subsidiary of DBP, Drugsson AB.High quality dietary supplements can substantially improve quality of life for people with impaired uptake of crucial nutrients from the diet and people with increased nutritional needs during a certain situation in life. It is therefore important to be able to introduce high quality products to the market that can match these needs and

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe